Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 31, Pages 3971-3979
Publisher
American Society of Clinical Oncology (ASCO)
Online
2013-10-08
DOI
10.1200/jco.2013.50.4910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI
- (2012) M. J. Wieduwilt et al. CLINICAL CANCER RESEARCH
- Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
- (2011) K. Fritsch et al. ANNALS OF ONCOLOGY
- Primary central nervous system lymphoma
- (2011) Jerome J. Graber et al. CURRENT OPINION IN NEUROLOGY
- Whole-brain radiotherapy in primary CNS lymphoma – Authors' reply
- (2011) Agnieszka Korfel et al. LANCET ONCOLOGY
- Whole-brain radiotherapy in primary CNS lymphoma
- (2011) Andrés JM Ferreri et al. LANCET ONCOLOGY
- Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy
- (2011) Patrick G. Morris et al. LEUKEMIA & LYMPHOMA
- Cognitive functions in primary CNS lymphoma after single or combined modality regimens
- (2011) D. D. Correa et al. NEURO-ONCOLOGY
- Rituximab monotherapy for patients with recurrent primary CNS lymphoma
- (2011) T. T. Batchelor et al. NEUROLOGY
- Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?
- (2010) Antonio Omuro et al. JOURNAL OF NEURO-ONCOLOGY
- High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
- (2010) Eckhard Thiel et al. LANCET ONCOLOGY
- Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma
- (2009) R.F. Barajas et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
- (2009) Andrés JM Ferreri et al. LANCET
- Therapeutic challenges in primary CNS lymphoma
- (2009) Patrick G Morris et al. LANCET NEUROLOGY
- Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy
- (2008) Meltem Ekenel et al. CANCER
- Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire
- (2008) Carole Soussain et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy
- (2008) Denise D. Correa et al. JOURNAL OF NEURO-ONCOLOGY
- Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study
- (2008) Hendrik Pels et al. JOURNAL OF NEURO-ONCOLOGY
- High-dose methotrexate for elderly patients with primary CNS lymphoma
- (2008) Jay-Jiguang Zhu et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started